Theophylline is able to partially revert cachexia in tumour-bearing rats

Overview of attention for article published in Nutrition & Metabolism, August 2012

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (80th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 1 X user
patent: 2 patents

facebook: 1 Facebook page

Readers on

mendeley: 41 Mendeley

Summary X Patents Facebook

So far, Altmetric has seen 2 patents that reference this research output.

SELECTIVE AT2 RECEPTOR AGONISTS FOR USE IN TREATMENT OF CACHEXIA

Application WO-2015014634-A1

World Intellectual Property Organisation (WIPO)

Selective AT2 receptor agonists for use in treatment of cachexia

Application EP-2832357-A1

European Patent Office

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.